TRAUMA YELLOW
  • Clinical
    • Discharge Macros
    • Procedure Macros
    • Exam Macros
    • Pediatric Macros
    • Antibiogram
    • Follow Up
    • 2023 MDM
    • Heart Pathway
    • Jeromy's Macros
  • Education
    • EM Education
    • Critical Care
    • FOAM
  • Orientation
    • Dept Orientation
    • Cerner
    • Dragon
  • Links
    • Clinical Links
    • StatMacros
    • ICU Bootcamp
  • Private
    • MCS
    • GWU Contacts & Map

From the TR: Pneumonia

7/13/2016

0 Comments

 
Picture

From the Teaching Resident: a quick review of how to treat any pneumonia patient

Community Acquired Pneumonia

Healthy Outpatient: no comorbidities or use of antimicrobials in the past 3 months
Treat with macrolide (strong, level 1) or doxycycline (weak, level 3)

At-Risk Outpatient: heart, lung, kidney, liver problems, diabetes, immunosuppressed, cancer, asplenic, antimicrobial use in the past 3 months
Treat with fluoroquinolone such as moxi,gemi,or levofloxacin (strong, level 1) or a beta lactam PLUS a macrolide (strong, level 1)

Inpatient CAP, ICU admission:
Treat with a fluoroquinolone (level 1) OR a beta lactam PLUS azithromycin (level 2). If penicillin allergic, fluoroquinolone plus aztreonam is the recommendation. 
If concerned about Pseudomonas, use an antipseudomonal beta lactam such as: pip/tazo, cefepime, imipenem, meropenem PLUS cipro or levofloxacin (750 mg). If penicillin allergic, aztreonam PLUS aminoglycoside PLUS fluoroquinolone. If fluoroquinolone allergic, beta lactam PLUS aminoglycoside PLUS azithromycin

Inpatient CAP, non-ICU admission:
Treat with beta lactam PLUS a macrolide (level 1) OR treat with a fluoroquinolone (level 1). 

Healthcare Associated Pneumonia (HCAP)

Please read the new, updated guidelines on HAP/VAP treatment! The below information is now considered out of date. 
Includes any patient who was hospitalized in an acute care hospital for two or more days within 90 days of the infection; resided in a nursing home or long-term care facility; received recent intravenous antibiotic therapy, chemotherapy, or wound care within the past 30 days of the current infection; or attended a hospital or hemodialysis clinic
Low suspicion for multi-drug resistant organisms:
Treat with ceftriaxone, fluoroquinolone, amp/sulbactam, or ertapenem. Remember, you are covering for CAP, plus MRSA and Pseudomonas. 

High suspicion for multi-drug resistant organisms:
Treat with vancomycin or linezolid PLUS cefepime or meropenem or pip/tazo PLUS cipro/levofloxacin or genta/tobramycin

You should have a high suspicion for MDR (MRSA, Pseudomonas, Acinetobacter) if: 
The patient has had prolonged duration of hospitalization (5 days or more), admission from a healthcare-related facility (nursing home, dialysis center), and recent prolonged antibiotic therapy (level 2). 
Picture
0 Comments



Leave a Reply.

    Categories

     

    All
    Abx
    Article
    Cardiac
    EKG
    EKG Challenge
    GI Bleed
    Grand Rounds
    Headache
    ICU
    Orthopedic
    Pain
    Peds
    Reading
    Stroke
    Subarachnoid Hemorrhage
    Syncope
    Teaching Pearl
    Trauma
    Travel
    Zika

    Archive

     

    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    January 2016
    December 2015
    November 2015

    Picture
    Please read our Terms of Use.
Donate
This site is independently owned and operated and not affiliated with the George Washington University, George Washington University Hospital, or Medical Faculty Associates. All information on this site is the opinion of the author alone and in no way should be seen to represent the views of the George Washington University, George Washington University Hospital, or Medical Faculty Associates. The information on this page is for personal use only and should not be see as medical advice or used directly for patient care. The author provides no guarantee of the accuracy of the information provided on this page. ​

​Please refer to our Terms of Use. 
  • Clinical
    • Discharge Macros
    • Procedure Macros
    • Exam Macros
    • Pediatric Macros
    • Antibiogram
    • Follow Up
    • 2023 MDM
    • Heart Pathway
    • Jeromy's Macros
  • Education
    • EM Education
    • Critical Care
    • FOAM
  • Orientation
    • Dept Orientation
    • Cerner
    • Dragon
  • Links
    • Clinical Links
    • StatMacros
    • ICU Bootcamp
  • Private
    • MCS
    • GWU Contacts & Map